INKT
MiNK Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.87
+1.37%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.35
- Revenue estimate
- $1.6M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.62
- EPS estimate
- -$0.60
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -11.4%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.60 | -$0.62 | Miss -3.33% | — |
| May 15, 2026 | -$0.77 | -$0.57 | Beat 25.97% | — |
| Nov 14, 2025 | -$0.86 | -$0.65 | Beat 24.42% | — |
| Aug 14, 2025 | -$0.55 | -$1.06 | Miss -92.73% | — |
| May 15, 2025 | -$0.61 | -$0.70 | Miss -14.75% | — |
| Mar 18, 2025 | -$0.50 | -$0.62 | Miss -24.00% | — |
| Nov 14, 2024 | -$0.80 | -$0.50 | Beat 37.50% | — |
| Mar 21, 2024 | -$1.50 | -$1.60 | Miss -6.67% | -$11.7B |
| Nov 9, 2023 | -$1.80 | -$1.50 | Beat 16.67% | — |
| Aug 10, 2023 | -$1.90 | -$1.80 | Beat 5.26% | — |
| May 11, 2023 | -$2.40 | -$1.70 | Beat 29.17% | $11.7B |
| Mar 21, 2023 | -$2.10 | -$2.30 | Miss -9.52% | $2.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026